Scandinavian ChemoTech AB (publ) (FRA:8V6)
Germany flag Germany · Delayed Price · Currency is EUR
0.287
-0.004 (-1.37%)
Last updated: Dec 5, 2025, 8:03 AM CET

Scandinavian ChemoTech AB Company Description

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida.

The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma.

It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa.

Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Scandinavian ChemoTech AB (publ)
Country Sweden
Founded 2013
Industry Electromedical and Electrotherapeutic Apparatus
Employees 6
CEO Stefan Frick

Contact Details

Address:
Medicon Village
Lund, 223 63
Sweden
Phone 46 1 02 18 93 00
Website chemotech.se

Stock Details

Ticker Symbol 8V6
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency SEK
SIC Code 3845

Key Executives

Name Position
Stefan Frick Chief Executive Officer
Ann Ohlsson Chief Financial Officer